NanoString Technologies Inc (NASDAQ:NSTG) Q2 2020 Earnings Conference Call - Final Transcript
Aug 10, 2020 • 04:30 pm ET
Ladies and gentlemen, thank you for standing by and welcome to the NanoString Second Quarter 2020 Operating Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Doug Farrell, Vice President, Investor Relations. Thank you. Please, go ahead.
Thank you, operator. Good afternoon, everyone. Joining me on the call today is Brad Gray, our President and CEO; and Tom Bailey our CFO. Earlier today we released our financial results for the second quarter of fiscal year 2020.
During this call we may make statements that are forward-looking, including statements about financial projections, the impact of the COVID-19 pandemic, existing and future collaborations, future business growth trends and related factors, prospects for expanding and penetrating our addressable markets, our strategic focus and objectives and the development status and anticipated success of recent and planned product offerings.
Forward-looking statements are subject to risks and uncertainties, many of which are beyond our control, including risks and uncertainties described from time to time in our SEC filings. Our results may differ materially from those projected and we undertake no obligation to update the forward-looking statements.
Later in the call, Tom will be reviewing our financial results. Consistent with our most recent earnings release, we have prepared a supplemental release to reconcile GAAP to non-GAAP measures. We believe this makes easier to interpret and compare our financial results. That can be found on the financial tab of our Investor Relations page on our website.
This afternoon's press release includes details regarding the definition and calculation of these non-GAAP measures, reconciliations to the near GAAP measure, as well as a discussion of the limitations and rationale for using non-GAAP measures. Throughout this call all financial measures will be GAAP, unless otherwise noted.
I'd like to remind you, we'll be participating in several virtual conferences in the third quarter, including the UBS Genomics 2.0 Conference later this week, as well as both the Baird & Morgan Stanley healthcare conferences in early September. We look forward to speaking with many of you then.
And now, I'd like to turn the call over to Brad.
Thanks, Doug. Good afternoon and thank you for joining us today. I hope that everyone remains healthy and productive in these challenging times. I'm excited to have this opportunity to share what we've accomplished over the last few months. I'd like to start by noting how proud I am of the way that the NanoString team adapted so quickly to the current operating environment, keeping our major R&D programs on schedule and maintaining the commercial momentum of the GeoMx launch.
During the call today, I'll give you a snapshot of our key Q2 operating results and update you on progress toward our strategic objectives, before handing off to Tom who'll cover our financial results and outlook.